查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1586282

膽固醇測試市場：按產品類型、測試項目、處方形式和最終用戶 - 2025-2030 年全球預測

Cholesterol Testing Market by Product Type (Test Kits, Testing Strips), Test (High-Density Lipoprotein, Low-Density Lipoprotein, Total Cholesterol Test), Test Type, Prescription Mode, End-Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年膽固醇檢測市值為189.7億美元，預計到2024年將達到207.2億美元，複合年成長率為9.71%，到2030年將達到363.1億美元。

膽固醇檢測是預防保健領域的重要組成部分，可作為評估心血管疾病風險的診斷工具。該市場的範圍由醫療機構、診斷中心和家庭檢測套組等應用定義。高血脂症和肥胖等與生活方式相關的疾病的日益流行，強調了膽固醇檢測的必要性，從而推動了定期篩檢的需求。最終使用領域包括醫院、診所和實驗室，所有這些都有助於公共衛生管理中廣泛的資料收集和分析。市場成長受到檢測設備技術進步、公眾意識提高以及政府促進定期健康檢查措施的影響。個人化醫療和數位健康技術的興起將帶來新的機會並擴大市場准入，特別是透過人工智慧主導的診斷工具和支援遠端監控和測試的行動醫療應用程式的整合。然而，由於先進測試解決方案的高成本、嚴格的監管標準以及與患者資料相關的隱私問題，市場成長面臨限制。此外，經濟差異可能會限制發展中地區獲得持續測試的機會。對公司來說有前景的創新領域包括開發非侵入性、經濟高效的測試和就地檢驗設備，直接為消費者帶來負擔得起的解決方案。生物標記物發現和物聯網設備整合以進行即時健康監測方面存在研究機會。市場格局的特點是競爭格局，許多公司努力透過創新提供差異化產品。為了取得成功，公司必須應對監管挑戰，投資消費者教育，並確保公平地獲得測試。與技術提供者的策略聯盟使我們能夠進一步提高我們的服務品質和市場覆蓋範圍，使我們能夠利用居家醫療和預防性醫療保健解決方案的轉變平衡。

主要市場統計
基準年[2023] 189.7億美元
預測年份 [2024] 207.2億美元
預測年份 [2030] 363.1億美元
複合年成長率（%） 9.71%

市場動態：揭示快速發展的膽固醇測試市場的關鍵市場洞察

供需的動態交互作用正在改變膽固醇檢測市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球心血管疾病流行
    • 由於飲食習慣的改變，肥胖人口迅速增加
    • 世界老年人口迅速增加
  • 市場限制因素
    • 非侵入性膽固醇檢測的可用性和自我檢測的偏好
  • 市場機會
    • 政府和私人組織積極進行定期膽固醇檢測宣傳活動
    • 醫療保健領域的強勁投資與技術進步
  • 市場挑戰
    • 嚴格的測試監理政策

波特五力：引領膽固醇測試市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解膽固醇測試市場的外部影響

外部宏觀環境因素在塑造膽固醇檢測市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解膽固醇檢測市場的競爭格局

對膽固醇測試市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣膽固醇測試市場供應商的績效評估

FPNV定位矩陣是評估膽固醇檢測市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製膽固醇測試市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對膽固醇測試市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球心血管疾病盛行率增加
      • 肥胖者的增加是由於飲食習慣的改變。
      • 世界各地的老年人口正在迅速增加。
    • 抑制因素
      • 自我測試的可用性和偏好以及非侵入性膽固醇測試的偏好
    • 機會
      • 政府和私人組織建議定期進行膽固醇測試
      • 對醫療保健和技術進步的大力投資
    • 任務
      • 嚴格的測試監理政策
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章膽固醇測試市場：依產品類型

  • 檢測套組
  • 試紙

第7章 膽固醇測試市場按測試

  • 高密度脂蛋白
  • 低密度脂蛋白
  • 總膽固醇測試

第8章按測試類型分類的膽固醇測試市場

  • 侵入性的
  • 非侵入性

第9章 膽固醇檢測市場處方箋模式

  • 在商店
  • 根據處方箋

第 10 章膽固醇測試市場：依最終用戶分類

  • 門診中心
  • 診所
  • 診斷中心
  • 居家護理
  • 醫院

第11章 北美和南美膽固醇檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區膽固醇檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲膽固醇檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • ACM Global Laboratories
  • Apollo Clinics
  • BioReference Health, LLC
  • Cell Biolabs, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Quest Diagnostics Incorporated
  • Randox Laboratories Ltd.
  • SEKISUI Diagnostics
  • Siemens Healthineers AG
  • SpectraCell Laboratories, Inc.
  • SYNLAB International GmbH
  • Thermo Fisher Scientific Inc.
  • Unilab Clinical Laboratory
Product Code: MRR-434CCDA04D1C

The Cholesterol Testing Market was valued at USD 18.97 billion in 2023, expected to reach USD 20.72 billion in 2024, and is projected to grow at a CAGR of 9.71%, to USD 36.31 billion by 2030.

Cholesterol testing is a critical component in the field of preventive healthcare, serving as a diagnostic tool to assess the risk of cardiovascular diseases. This market's scope is defined by its applications across medical facilities, diagnostic centers, and home testing kits. The necessity of cholesterol testing is underscored by the increasing prevalence of lifestyle-related conditions such as hyperlipidemia and obesity, driving demand for regular screening. End-use sectors include hospitals, clinics, and research laboratories, all of which contribute to extensive data collection and analysis in public health management. Market growth is influenced by technological advancements in testing equipment, heightened public awareness, and government initiatives promoting regular health check-ups. The rise of personalized medicine and digital health technologies presents new opportunities, specifically through the integration of AI-driven diagnostic tools and mobile health apps that enable remote monitoring and testing, thus expanding market accessibility. However, market growth faces limitations due to high costs of advanced testing solutions, stringent regulatory standards, and privacy concerns related to patient data. Additionally, economic disparities may limit access to continuous testing in developing regions. For businesses, promising areas of innovation include the development of non-invasive and cost-effective testing methods, as well as point-of-care testing devices that bring affordable solutions directly to consumers. Research opportunities lie in biomarker discovery and integration of IoT devices for real-time health monitoring. The cholesterol testing market is characterized by a competitive landscape with numerous players striving to offer differentiated products through innovation. Successful navigation requires companies to address regulatory challenges, invest in consumer education, and ensure equitable access to testing. Strategic collaborations with technology providers can further enhance service quality and market reach, positioning firms to capitalize on the shifting balance toward home-based and preventive healthcare solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 18.97 billion
Estimated Year [2024] USD 20.72 billion
Forecast Year [2030] USD 36.31 billion
CAGR (%) 9.71%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cholesterol Testing Market

The Cholesterol Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of cardiovascular diseases worldwide
    • Proliferation in number of obese people attributed to changing eating habits
    • Surge in the geriatric population across the globe
  • Market Restraints
    • Availability and preference over self-testing and preference for non-invasive cholesterol tests
  • Market Opportunities
    • Favorable government and private organization campaigns to undergo regular cholesterol checkups
    • Robust investment in healthcare and technological advancements
  • Market Challenges
    • Strict regulatory policies in testing

Porter's Five Forces: A Strategic Tool for Navigating the Cholesterol Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cholesterol Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cholesterol Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cholesterol Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cholesterol Testing Market

A detailed market share analysis in the Cholesterol Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cholesterol Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cholesterol Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cholesterol Testing Market

A strategic analysis of the Cholesterol Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cholesterol Testing Market, highlighting leading vendors and their innovative profiles. These include ACM Global Laboratories, Apollo Clinics, BioReference Health, LLC, Cell Biolabs, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Merck KGaA, Quest Diagnostics Incorporated, Randox Laboratories Ltd., SEKISUI Diagnostics, Siemens Healthineers AG, SpectraCell Laboratories, Inc., SYNLAB International GmbH, Thermo Fisher Scientific Inc., and Unilab Clinical Laboratory.

Market Segmentation & Coverage

This research report categorizes the Cholesterol Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Test Kits and Testing Strips.
  • Based on Test, market is studied across High-Density Lipoprotein, Low-Density Lipoprotein, and Total Cholesterol Test.
  • Based on Test Type, market is studied across Invasive and Non-Invasive.
  • Based on Prescription Mode, market is studied across Over the Counter and Prescription-Based.
  • Based on End-Users, market is studied across Ambulatory Centers, Clinics, Diagnostic Centers, Homecare, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of cardiovascular diseases worldwide
      • 5.1.1.2. Proliferation in number of obese people attributed to changing eating habits
      • 5.1.1.3. Surge in the geriatric population across the globe
    • 5.1.2. Restraints
      • 5.1.2.1. Availability and preference over self-testing and preference for non-invasive cholesterol tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Favorable government and private organization campaigns to undergo regular cholesterol checkups
      • 5.1.3.2. Robust investment in healthcare and technological advancements
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory policies in testing
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cholesterol Testing Market, by Product Type

  • 6.1. Introduction
  • 6.2. Test Kits
  • 6.3. Testing Strips

7. Cholesterol Testing Market, by Test

  • 7.1. Introduction
  • 7.2. High-Density Lipoprotein
  • 7.3. Low-Density Lipoprotein
  • 7.4. Total Cholesterol Test

8. Cholesterol Testing Market, by Test Type

  • 8.1. Introduction
  • 8.2. Invasive
  • 8.3. Non-Invasive

9. Cholesterol Testing Market, by Prescription Mode

  • 9.1. Introduction
  • 9.2. Over the Counter
  • 9.3. Prescription-Based

10. Cholesterol Testing Market, by End-Users

  • 10.1. Introduction
  • 10.2. Ambulatory Centers
  • 10.3. Clinics
  • 10.4. Diagnostic Centers
  • 10.5. Homecare
  • 10.6. Hospitals

11. Americas Cholesterol Testing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Cholesterol Testing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Cholesterol Testing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ACM Global Laboratories
  • 2. Apollo Clinics
  • 3. BioReference Health, LLC
  • 4. Cell Biolabs, Inc.
  • 5. Eurofins Scientific SE
  • 6. F. Hoffmann-La Roche Ltd.
  • 7. Merck KGaA
  • 8. Quest Diagnostics Incorporated
  • 9. Randox Laboratories Ltd.
  • 10. SEKISUI Diagnostics
  • 11. Siemens Healthineers AG
  • 12. SpectraCell Laboratories, Inc.
  • 13. SYNLAB International GmbH
  • 14. Thermo Fisher Scientific Inc.
  • 15. Unilab Clinical Laboratory

LIST OF FIGURES

  • FIGURE 1. CHOLESTEROL TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. CHOLESTEROL TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CHOLESTEROL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CHOLESTEROL TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CHOLESTEROL TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CHOLESTEROL TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CHOLESTEROL TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CHOLESTEROL TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CHOLESTEROL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CHOLESTEROL TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY TESTING STRIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY HIGH-DENSITY LIPOPROTEIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY LOW-DENSITY LIPOPROTEIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY TOTAL CHOLESTEROL TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY NON-INVASIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES CHOLESTEROL TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 235. CHOLESTEROL TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 236. CHOLESTEROL TESTING MARKET, FPNV POSITIONING MATRIX, 2023